Premium
Combined therapy with low‐dose omalizumab and intravenous immunoglobulin for severe atopic dermatitis. Report of four cases
Author(s) -
Toledo F.,
Silvestre J.F.,
Muñoz C.
Publication year - 2012
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2011.04326.x
Subject(s) - medicine , omalizumab , atopic dermatitis , dermatology , intravenous immunoglobulin therapy , antibody , immunoglobulin e , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom